Ever Fortune.AI Co. Ltd. (6841.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan

Price
53.30 TWD
Market cap
4.74 bn TWD
P/E (2025)
–
P/S (2025)
12.50
Dividend yield
1.88 %
Net margin
22.00 %
Return on equity (ROE)
–
Return on assets (ROA)
–

Ever Fortune.AI Co. Ltd. financials

Fiscal year20242025
Revenue337.52 m TWD378.81 m TWD
Gross profit207.81 m TWD224.93 m TWD
Operating income30.54 m TWD38.56 m TWD
EBIT56.74 m TWD125.63 m TWD
Net income30.31 m TWD83.35 m TWD

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Ever Fortune.AI Co. Ltd.

Ever Fortune.AI Co., Ltd., an cloud-based biomedical platform, provides medical artificial intelligence (AI) solutions and services in China. The company offers medical AI solutions, such as oncology radiotherapy, emergency radiology, computer assisted detection platform for bone scintigraphy, cardio suite SPECT myocardial perfusion agile workflows; and cloud medical, genetic testing AI analysis, smart health check-up scheduling, haircare AI cloud, and underwriting claims medical image recognition platform. It also provides Biotech and Beauty solutions including renexo miracle skin essence, hair revitalizing essence. Ever Fortune.AI Co., Ltd. was founded in 1998 and is based in Taichung, Taiwan. Ever Fortune.AI Co., Ltd. operates as a subsidiary of An Ji Biomedical Corporation.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.